H19 and cholangiocarcinoma: Based on the studies discussed in this review, H19 seems to induce drug resistance in ESCA, CRC, GC, and gallbladder cancer; however, it has a dual effect in promoting or inhibiting drug resistance in HCC, CCA, and PDAC.